Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 40,181 | 30,080 | 21,878 | 4,457 | 1,913 |
| Operating Income | -40,181 | -30,080 | -21,878 | -4,457 | -1,913 |
| Interest Expense | 3,034 | 0 | 0 | 2 | 0 |
| Other Income | 521 | 1,873 | 1,230 | 0 | 0 |
| Pre-tax Income | -42,694 | -28,207 | -20,648 | -4,459 | -1,913 |
| Net Income Continuous | -42,694 | -28,207 | -20,648 | -4,459 | -1,913 |
| Net Income | $-42,694 | $-28,207 | $-20,648 | $-4,459 | $-1,913 |
| EPS Basic Total Ops | -17.10 | -11.30 | -14.10 | -34.20 | -5.20 |
| EPS Basic Continuous Ops | -17.08 | -11.33 | -14.08 | -15.60 | -5.20 |
| EPS Diluted Total Ops | -17.10 | -11.30 | -14.10 | -34.20 | -5.20 |
| EPS Diluted Continuous Ops | -17.08 | -11.33 | -14.08 | -15.60 | -5.20 |
| EPS Diluted Before Non-Recurring Items | -17.10 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-39,952 | $-29,823 | $-21,858 | $-4,457 | $-1,913 |